IQVIA Institute for Human Data Science’s Post

What’s driving the expected increase in oncology spending over the next five years? 🟢early diagnosis of patients 🟢continued introduction of new drugs 🟢wider access to novel cancer drugs in more countries beyond the major developed countries where they often launch first 🟢longer treatments for medicines with survival benefits Learn more about global oncology spending and growth in the Institute’s annual The Global Use of Medicines 2024: Outlook to 2028 report: https://bit.ly/3PDUWRy. #GlobalHealth

  • No alternative text description for this image
Adil Tanveer

Strategy | Commercial | Sales & Marketing | Digital | Leadership

7mo

Most mergers and acquisitions, oncology. Most new trial starts, oncology. Most patent expiries, oncology. Highest 5 year future CAGR, oncology.

To view or add a comment, sign in

Explore topics